Showing results (1601-1610 of 1,828) with videos related to
Sort By:
Pageof 183
Bioorganic & Medicinal Chemistry|December 4, 2003
Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PETGaëlle Roger, Béatrice Lagnel, Jacques Rouden, et al.Oncotarget|September 19, 2015
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patientsElisa Zuffa, Eugenia Franchini, Cristina Papayannidis, et al.Cells|February 25, 2023
Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in RatsMatthieu Leuillier, Valentin Platel, Ly Tu, et al.Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.Il Giornale Di Chirurgia|March 20, 2010
[Unusual cause of acute abdomen in adult patient: gallstone ileus]E Spaziani, C Vergaro, M Picchio, et al.Dementia & Neuropsychologia|April 24, 2018
On the use of the P300 as a tool for cognitive processing assessment in healthy aging: A reviewSofia Cristina Iost Pavarini, Allan Gustavo Brigola, Bruna Moretti Luchesi, et al.Clinical Oral Investigations|April 5, 2025
Obsessive-compulsive symptoms and traits in patients with burning mouth syndrome: a cross-sectional multicentric analysisLuca Pellegrini, Federica Canfora, Giulia Ottaviani, et al.Haematologica|May 10, 2007
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrowLuca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.Journal of Thrombosis and Thrombolysis|August 15, 2013
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic strokeManuel Cappellari, Giuseppe Moretto, Nicola Micheletti, et al.Pageof 183